Autologous biologics, defined as platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMC), are cell-based therapy treatment options in regenerative medicine practices, and have been increasingly used in orthopedics, sports medicine, and spinal disorders. These biological products are produced at point-of-care; thereby, avoiding expensive and cumbersome culturing and expansion techniques. Numerous commercial PRP and BMC systems are available but reports and knowledge of bio-cellular formulations produced by these systems are limited. This limited information hinders evaluating clinical and research outcomes and thus making conclusions about their biological effectiveness. Some of their important cellular and protein properties have not been characterized, which is critical for understanding the mechanisms of actions involved in tissue regenerative processes. The presence and role of red blood cells (RBCs) in any biologic has not been addressed extensively. Furthermore, some of the pathophysiological effects and phenomena related to RBCs have not been studied. A lack of a complete understanding of all of the biological components and their functional consequences hampers the development of clinical standards for any biological preparation. This paper aims to review the clinical implications and pathophysiological effects of RBCs in PRP and BMC; emphasizes hemolysis, eryptosis, and the release of macrophage inhibitory factor; and explains several effects on the microenvironment, such as inflammation, oxidative stress, vasoconstriction, and impaired cell metabolism.
Keywords: BM-MSCs, bone marrow-mesenchymal cells; BMA, bone marrow aspiration; BMC, bone marrow concentrate; Bone marrow mesenchymal cells; Eryptosis; HSCs, hematopoietic stem cells; Hb, hemoglobin; Hp, haptoglobin; Hx, hemopexin; Inflammation; MIF, Macrophage migration inhibitory factor; MNCs, mononucleated cells; Macrophage migration inhibitor factor; NO, nitric oxide; OA, osteoarthritis; Oxidative stress; PAF, platelet activating factor; PFH, plasma free hemoglobin; PRP, platelet-rich plasma; PS, phosphatidylserine; Plasma free hemoglobin; Platelet-rich plasma; RBC, red blood cell; ROS, reactive oxygen species.